Annexon (ANNX) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

ANNX is expected to report earnings to rise 11.80% to -27 cents per share on March 20

Q4'24

Est.

$-0.28

Q3'24

Beat

by $0.01

Q2'24

Est.

$-0.23

Q1'24

Beat

by $0.13

Q4'23

Beat

by $0.09

The last earnings report on November 14 showed earnings per share of -25 cents, beating the estimate of -25 cents. With 796.05K shares outstanding, the current market capitalization sits at 668.79M.

View a ticker or compare two or three

Compare

ANNX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ANNX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for ANNX (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

1400 Sierra Point Parkway

Phone

+1 650 822-5500

Employees

Web

https://www.annexonbio.com